Figures & data
Figure 1. Schematic of approaches to an artificial pancreas. A broad spectrum of automated insulin delivery systems is under development, ranging from insulin suspension for reaching or approaching hypoglycemia, through night-time only closed-loop (CL) to full-day CL. Some systems retain the requirement for manual insulin dosing for meals (HCL), whereas others are fully automated. Finally, systems may include insulin only (Unihorm) or may incorporate other hormones (Bihorm). As these systems increase in automation and complexity, the need for user input decreases, but may be met by a compensatory increase in challenge to commercialization.
